IHF:NYE-iShares U.S. Healthcare Providers ETF (USD)

ETF | Health |

Last Closing

USD 51.06

Change

+0.03 (+0.06)%

Market Cap

N/A

Volume

0.10M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-22 )

Largest Industry Peers for Health

Symbol Name Price(Change) Market Cap
XLV Health Care Select Sector SPDR..

-0.32 (-0.22%)

USD 37.80B
FHLC Fidelity® MSCI Health Care In..

-0.03 (-0.04%)

USD 2.66B
FXH First Trust Health Care AlphaD..

-0.34 (-0.31%)

USD 1.07B
XHE SPDR® S&P Health Care Equipme..

-0.09 (-0.10%)

USD 0.21B
IDNA iShares Genomics Immunology an..

-0.02 (-0.09%)

USD 0.12B
SBIO ALPS Medical Breakthroughs ETF

+0.22 (+0.68%)

USD 0.09B
XHS SPDR® S&P Health Care Service..

+0.07 (+0.07%)

USD 0.07B
HTEC Robo Global® Healthcare Techn..

+0.17 (+0.56%)

USD 0.05B
BBP Virtus LifeSci Biotech Product..

+0.42 (+0.68%)

USD 0.02B
BBC Virtus LifeSci Biotech Clinica..

+0.35 (+1.55%)

USD 8.55M

ETFs Containing IHF

MSSS Northern Lights Fund Trus.. 9.86 % 0.00 %

-0.01 (-0.04%)

USD 0.11B

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.40% 76% C+ 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.40% 76% C+ 82% B
Trailing 12 Months  
Capital Gain -1.49% 10% F 26% F
Dividend Return 0.79% 56% F 9% A-
Total Return -0.69% 14% F 21% F
Trailing 5 Years  
Capital Gain 26.22% 52% F 63% D
Dividend Return 5.15% 63% D 14% F
Total Return 31.38% 52% F 56% F
Average Annual (5 Year Horizon)  
Capital Gain 5.55% 57% F 52% F
Dividend Return 6.19% 62% D 47% F
Total Return 0.64% 63% D 16% F
Risk Return Profile  
Volatility (Standard Deviation) 21.71% 43% F 50% F
Risk Adjusted Return 28.50% 57% F 42% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.